Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000339423

Medchemexpress LLC SPR719 | 1384984-18-2 | 99.4% | 10 MG
SDP

Catalog No. 5000339423
Encompass_Preferred

SPR719 (VXc-486) is an orally active gyrase B inhibitor with bactericidal activity. It potently inhibits multiple agent-sensitive and drug-resistant isolates of Mycobacterium tuberculosis, making it promising for research into lung diseases caused by non-tuberculous mycobacteria (NTM).

  • Potently inhibits multiple agent-sensitive and drug-resistant isolates of Mycobacterium tuberculosis.
  • Shows bactericidal activity.
  • Research compound for lung diseases caused by non-tuberculous mycobacteria (NTM).
  • Orally active gyrase B inhibitor.
  • Inhibits M. tuberculosis replication in macrophages.

Catalog No. 50-003-39423 Supplier Medchemexpress LLC Supplier No. HY1293010MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

SPR719 (VXc-486) is an orally active gyrase B inhibitor with bactericidal activity. It potently inhibits multiple agent-sensitive and drug-resistant isolates of Mycobacterium tuberculosis, making it promising for research into lung diseases caused by non-tuberculous mycobacteria (NTM).

  • Potently inhibits multiple agent-sensitive and drug-resistant isolates of Mycobacterium tuberculosis.
  • Shows bactericidal activity.
  • Research compound for lung diseases caused by non-tuberculous mycobacteria (NTM).
  • Orally active gyrase B inhibitor.
  • Inhibits M. tuberculosis replication in macrophages.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.